These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37855160)

  • 1. Association between calcium channel blockers and the severity of actinic keratosis on face and scalp: a cross-sectional study.
    Gioppo IS; de Castro Martins IM; Santos SS; Preto JFR; Miola AC; Miot HA
    Int J Dermatol; 2023 Dec; 62(12):1511-1519. PubMed ID: 37855160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daylight photodynamic therapy for severe facial and scalp actinic keratosis: a prospective non-sponsored single-centre study employing the actinic keratosis area and severity index (AKASI).
    Jordan M; Ghoreschi K; Eberle FC
    Eur J Dermatol; 2019 Feb; 29(1):67-74. PubMed ID: 30827943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index.
    Dirschka T; Pellacani G; Micali G; Malvehy J; Stratigos AJ; Casari A; Schmitz L; Gupta G;
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1295-1302. PubMed ID: 28401585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
    Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M
    Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial.
    Puviani M; Galloni C; Marchetti S; Sergio Pavone P; Lovati S; Pistone G; Caputo V; Tilotta G; Scarcella G; Campione E; Diluvio L; Garofalo V; Bianchi L; Milani M
    Curr Med Res Opin; 2017 Jul; 33(7):1255-1259. PubMed ID: 28358282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for actinic keratosis in eight European centres: a case-control study.
    Traianou A; Ulrich M; Apalla Z; De Vries E; Bakirtzi K; Kalabalikis D; Ferrandiz L; Ruiz-de-Casas A; Moreno-Ramirez D; Sotiriadis D; Ioannides D; Aquilina S; Apap C; Micallef R; Scerri L; Pitkänen S; Saksela O; Altsitsiadis E; Hinrichs B; Magnoni C; Fiorentini C; Majewski S; Ranki A; Proby CM; Stockfleth E; Trakatelli M;
    Br J Dermatol; 2012 Aug; 167 Suppl 2():36-42. PubMed ID: 22881586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actinic keratosis area and severity index is not correlated with photodynamic therapy procedural pain.
    Sharma A; Vincent L
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101946. PubMed ID: 32795507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial.
    Agozzino M; Russo T; Franceschini C; Mazzilli S; Garofalo V; Campione E; Bianchi L; Milani M; Argenziano G
    Curr Med Res Opin; 2019 Oct; 35(10):1785-1792. PubMed ID: 31148490
    [No Abstract]   [Full Text] [Related]  

  • 9. Daylight photodynamic therapy: experience in the treatment of actinic keratosis in the San Gallicano Institute (Rome) and a review of literature.
    Carbone A; Sperduti I; De Simone P; Piemonte P; Ferrari A; Buccini P; Silipo V; Iorio A; Frascione P; Eibenschutz L
    G Ital Dermatol Venereol; 2020 Jun; 155(3):312-319. PubMed ID: 29368865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
    Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
    Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
    Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Actinic Keratosis and Severity Index with Physician Global Assessment and Total Lesion Count and the Ability to Predict Skin Cancer.
    Acar A; Karaarslan I
    Dermatol Pract Concept; 2022 Feb; 12(1):e2022031. PubMed ID: 35223175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Actinic Keratosis Field Assessment Scale for Grading Actinic Keratosis Disease Severity.
    Dréno B; Cerio R; Dirschka T; Nart IF; Lear JT; Peris K; de Casas AR; Kaleci S; Pellacani G
    Acta Derm Venereol; 2017 Oct; 97(9):1108-1113. PubMed ID: 28536731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of skin cancer and actinic keratosis-related knowledge and sun protection behaviors and sunscreen use among a sample of Jordanian population.
    Saleh MM; Awwad O; Abdel Jalil MH; Al-Qerem W; Saleh M; Al Thaher Y; Abdelghany S
    J Cosmet Dermatol; 2022 Dec; 21(12):7066-7074. PubMed ID: 36086979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.
    Neri L; Peris K; Longo C; Calvieri S; Frascione P; Parodi A; Eibenschuz L; Bottoni U; Pellacani G;
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):93-107. PubMed ID: 29920789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
    Puviani M; Barcella A; Milani M
    G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-level light-assisted photodynamic therapy using a wearable cap-like device for the treatment of actinic keratosis of the scalp.
    Fonda-Pascual P; Alegre-Sánchez A; Harto-Castaño A; Moreno-Arrones OM; Pérez-García B; González-Morales ML; Pindado-Ortega C; Gilaberte-Calzada Y; Aguilera J; Jaen-Olasolo P; Fernández-Guarino M
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():136-141. PubMed ID: 30508663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of a short illumination duration (1 hour) when performing photodynamic therapy of actinic keratosis using the Dermaris light source.
    Creusot M; Mordon S
    Photodiagnosis Photodyn Ther; 2021 Dec; 36():102618. PubMed ID: 34743007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.